Skip to content
Close menu

SBRI HEALTHCARE

Search our Innovation Portfolio

Find a company

Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.

If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.

We would be happy to make introductions to the companies or provide any further feedback you require.

At a glance

10
Companies funded
£4,044,416
Total funding

Directory search results

C the Signs Limited

Project C the Signs - Fighting Cancer with Early Diagnosis
Description

By 2020 one in two people in the UK will be diagnosed with Cancer at some point in their life. Approximately 50% will be diagnosed late, with an associated 80% mortality. Our innovation, C the Signs, is a digital tool (App & website) that uses the latest evidence to help GPs identify patients with suspected Cancer early. Covering the entire spectrum of Cancer and cross-referencing multiple diagnostic pathways, C the Signs can support GPs in recommending what tests, investigations or referrals a patient may need in under 30 seconds.

Funding £ 916,266
Competition Competition 13 - Cancer: screening, earlier and faster diagnosis
Competition Date September 2017
Categories Cancer , Health inequalities
Health Innovation Network Partner Eastern AHSN
Website https://cthesigns.co.uk

Aidence BV

Project Lung cancer screening pathway powered by Artificial Intelligence
Description

Aidence provides Artificial Intelligence (AI) solutions for analyses of medical images and data. Lung CAD (L-CAD) is the company’s first CE-certified software providing highly accurate detection and reporting of pulmonary nodules on CT-chest. Initially, L-CAD supports radiologists as a second reader, enabling shorter reading times and improving diagnostic accuracy.

However, we propose to develop L-CAD as first reader, reducing the radiology burden by autonomously reporting follow up studies or even acting as a filter to remove unsuspicious studies from the workflow. L-CAD is an enabler of a safe and efficient lung screening program.

Funding £ 83,333
Competition Competition 13 - Cancer: screening, earlier and faster diagnosis
Competition Date September 2017
Categories Respiratory , Cancer
Website http://aidence.com/

Cambridge Oncometrix Limited

Project Prostate Liquid Biopsy Test for Risk Stratificatio for Prostate Cancer
Description

Cambridge Oncometrix is developing a non-invasive Prostate Liquid Biopsy test for risk stratification of men suspected of prostate cancer. The test measures the chemical element profile of semen, which changes significantly when a tumour is present in the prostate.

Prostate Liquid Biopsy is non-invasive and simple to administer, and will improve treatment outcomes by diagnosing prostate cancer earlier. The test will aid identification of men who will benefit from prostate biopsy and those who could safely forgo it, which will reduce the number of invasive biopsy procedures and post-biopsy complications, improve patients’ experience and aid efficient use of NHS resources.

Funding £ 916,070
Competition Competition 13 - Cancer: screening, earlier and faster diagnosis
Competition Date September 2017
Categories Cancer
Health Innovation Network Partner Eastern AHSN
Website https://cambridgeoncometrix.com/

Subscribe

Subscribe to the SBRI Healthcare newsletter and receive the latest competition information & latest news updates.